Talkspace (TALK) Competitors $2.66 0.00 (0.00%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$2.66 0.00 (0.00%) As of 08/29/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. ARDT, PACS, NHC, VRDN, AVAH, TDOC, AHCO, GRAL, OMDA, and PNTGShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Ardent Health (ARDT), PACS Group (PACS), National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), Teladoc Health (TDOC), AdaptHealth (AHCO), GRAIL (GRAL), Omada Health (OMDA), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors Ardent Health PACS Group National HealthCare Viridian Therapeutics Aveanna Healthcare Teladoc Health AdaptHealth GRAIL Omada Health The Pennant Group Ardent Health (NYSE:ARDT) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability. Which has higher valuation and earnings, ARDT or TALK? Ardent Health has higher revenue and earnings than Talkspace. Ardent Health is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdent Health$5.97B0.30$210.34M$1.817.01Talkspace$187.59M2.37$1.15M$0.02133.00 Which has more volatility and risk, ARDT or TALK? Ardent Health has a beta of 0.29, suggesting that its stock price is 71% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Does the media refer more to ARDT or TALK? In the previous week, Ardent Health had 4 more articles in the media than Talkspace. MarketBeat recorded 7 mentions for Ardent Health and 3 mentions for Talkspace. Talkspace's average media sentiment score of 1.53 beat Ardent Health's score of 1.23 indicating that Talkspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Talkspace 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals hold more shares of ARDT or TALK? 57.4% of Talkspace shares are held by institutional investors. 1.7% of Ardent Health shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate ARDT or TALK? Ardent Health currently has a consensus price target of $19.56, suggesting a potential upside of 54.22%. Talkspace has a consensus price target of $4.50, suggesting a potential upside of 69.17%. Given Talkspace's stronger consensus rating and higher possible upside, analysts plainly believe Talkspace is more favorable than Ardent Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00 Is ARDT or TALK more profitable? Ardent Health has a net margin of 4.11% compared to Talkspace's net margin of 1.41%. Ardent Health's return on equity of 16.66% beat Talkspace's return on equity.Company Net Margins Return on Equity Return on Assets Ardent Health4.11% 16.66% 5.18% Talkspace 1.41%2.48%2.11% SummaryTalkspace beats Ardent Health on 9 of the 17 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$445.46M$2.05B$5.71B$9.76BDividend YieldN/AN/A6.66%4.48%P/E Ratio133.0738.0183.1026.57Price / Sales2.379.74544.91112.35Price / Cash223.8852.0425.6628.92Price / Book3.8610.7911.766.08Net Income$1.15M-$63.67M$3.27B$265.84M7 Day Performance0.38%-0.71%1.13%0.36%1 Month Performance15.15%10.44%8.30%5.58%1 Year Performance33.00%30.31%62.26%19.67% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace4.127 of 5 stars$2.66flat$4.50+69.2%+33.0%$445.46M$187.59M133.07500Positive NewsARDTArdent Health3.4258 of 5 stars$12.70-2.2%$19.56+54.1%-36.0%$1.86B$5.97B7.0124,900Positive NewsPACSPACS Group2.859 of 5 stars$11.75-2.5%$33.33+183.7%-70.7%$1.84B$3.56B0.0032,433NHCNational HealthCareN/A$111.98-2.5%N/A-17.2%$1.74B$1.46B14.0312,400Positive NewsVRDNViridian Therapeutics1.8678 of 5 stars$18.57-3.4%$37.78+103.4%+25.2%$1.57B$300K-4.8550News CoveragePositive NewsAVAHAveanna Healthcare2.3772 of 5 stars$7.43-0.5%$7.50+0.9%+41.6%$1.56B$2.02B92.8833,500Positive NewsTDOCTeladoc Health2.9545 of 5 stars$7.67-0.1%$9.75+27.1%+7.9%$1.36B$2.54B-6.455,500Positive NewsAHCOAdaptHealth4.1076 of 5 stars$9.23-4.0%$13.40+45.2%-13.6%$1.30B$3.26B17.0910,500Positive NewsGRALGRAIL1.0008 of 5 stars$32.92-3.9%$31.50-4.3%+132.4%$1.23B$125.60M-2.511,360News CoverageOMDAOmada HealthN/A$21.00-1.5%$24.57+17.0%N/A$1.23BN/A0.00849PNTGThe Pennant Group4.2557 of 5 stars$24.64-2.1%$33.40+35.6%-29.9%$869.92M$695.24M31.597,000News CoveragePositive News Related Companies and Tools Related Companies Ardent Health Competitors PACS Group Competitors National HealthCare Competitors Viridian Therapeutics Competitors Aveanna Healthcare Competitors Teladoc Health Competitors AdaptHealth Competitors GRAIL Competitors Omada Health Competitors The Pennant Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TALK Stock Alerts